We investigated the density and distribution of nitric oxide synthase (NOS) binding by quantitative autora diography using [3H]L-NJ-nitroarginine WH]L-NNA) after transient focal ischemia or intrastriatal injection of N methyl-D-aspartate (NMDA) in wild-type (SV-129 and C57black/6) and type I (neuronal) and type III (endothe lial) NOS-deficient mice. The middle cerebral artery (MCA) was occluded by an intraluminal filament for 3 h followed by 10 min<to 7 days of reperfusion. Specific [3H]L NNA binding, observed in the wild-type and type III mu tant mouse at baseline, increased by 50-250% in the MeA territory during ischemia and the first 3 h of reperfusion. The density of binding sites (8max), but not the dissociation constant (Kd), increased significantly during the ischemic period as did type I NOS mRNA as detected by quantitative reverse transcription polymerase chain reaction.
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NNA binding after intrastriatal NMDA injection also in creased by 20-230%. In the type I NOS-deficient mouse, [3H]L-NNA binding was low and only a very small increase was observed after ischemia or excitotoxicity. Under condi tions of this study, [3H]L-NNA did not bind to type II NOS as there was no difference in the distribution or density of [3H]L-NNA binding in the rat spleen obtained after lipopolysaccharide treatment despite induction of NOS type II catalytic activity. Our data suggest that an ischemic/ excitotoxic insult up-regulates type I NOS gene expres sion and [3H]L-NNA binding and that this up-regulation may play a pivotal role in the pathogenesis of ischemic/ excitotoxic diseases. Key Words: Autoradiography-Ex citotoxicity-Ischemia-N-Methyl-D-aspartate-Mutant mouse-Nitric oxide synthase. tion increases after transient middle cerebral artery (MCA) occlusion (Malinski et ai., 1993; Kumura et ai., 1994; Zhang et ai., 1994) . Accumulated evidence suggests that enhanced synthesis of NO by type I NOS is deleterious in ischemia. In particular, type I NOS mutant mice were resistant to injury after permanent (Huang et ai., 1994) or transient (Hara et ai., 1996a) focal ischemia. Type III NOS-deficient mice developed larger lesions after MCA occlusion, and these lesions decreased after L-�-nitroarginine (L-NNA) treatment (Huang et ai., 1996) . Excitotoxic lesions following intrastriatal N-methyl-o-aspartate (NMDA) injections were smaller in type I NOS mu tant mice (Ayata et ai., 1996) . Cultured cortical cells from type I NOS mutant mice appear relatively resis tant to NMDA neurotoxicity (Dawson et ai., 1996) . Hence, NO production within endothelium may pro tect brain tissue against ischemic injury, whereas neu ronal NO overproduction may lead to neurotoxicity. PH]L-NNA, a 3H-labeled analogue of L-arginine, was used to characterize NOS isoforms in rat brain homogenates, rat brain tissue sections, and human placenta (Michel et aI., 1993; Burazin and Gundlach, 1995; Kidd et aI., 1995; Rutherford et aI., 1995) . The data suggest that the ligand may bind type I and type III NOS. Although type I NOS is the major [3H]L NNA binding site in mouse brain (Hara et aI., 1996b) , it is not known whether [3H]L-NNA labels type II NOS in brain tissue sections. Type II NOS has been implicated in ischemic pathophysiology (Iadecola et aI., 1995) . We have thus studied [3H]L-NNA binding in rat spleen after inducing NOS catalytic activity with lipopolysaccharide (LPS) injection. Here, we report that [3H]L-NNA binds to type I and type III NOS selectively and that the density of [3H]L-NNA binding increases following transient ischemia or in trastriatal NMDA injection. Part of this work has been published in preliminary form (Ayata et aI., 1996; Hara et aI., 1996c) .
MATERIALS AND METHODS

Animals
Wild-type (adult male SV-129 and C57black/6; Taconic Farms, Germantown, NY, U.S.A.) and type I (adult male and female) (Huang et ai., 1993) and type III (Huang et ai., 1995) NOS mutant mice weighing 20-28 g and Sprague Dawley r!ts (adult male; Charles River Laboratory, Wil mington, MA, U.S.A.) weighing 350-400 g were allowed free access to food and water. Wild-type (type I NOS+1 +), and heterozygote (type I NOS+' -) littermate controls in addition to homozygotes (type I NOS-1 -) were used in NMDA excitotoxicity experiments. Pig aorta was obtained from Pel-Freeze Biologicals (Rogers, AR, U.S.A.). LPS (Klebsiella pneumoniae) was purchased from Sigma Chemi cal Co. (St. Louis, MO, U.S.A.).
Physiology
Animals were initially anesthetized with 1 % and main tained by 0.5-1 % halothane in 70% N20/30% O2 (Fluotec 3 vaporizer; Colonial Medical, Amherst, NH, U.S.A.). Re gional CBF (rCBF) was determined by laser-Doppler flowmetry (PF2B; Perimed, Stockholm, Sweden) using a flexible 0.5-mm fiberoptic extension to the master probe. The tip of the probe was fixed to the intact skull with cyanoacrylate glue (Aron Alpha, Toa, Tokyo, Japan) over the ischemic cortex (2 mm posterior and 6 mm lateral to bregma). Steady-state baseline values were recorded be fore MCA occlusion, and rCBF during and after occlusion was expressed as percentage of the baseline values. rCBF, blood pressure, and heart rate were monitored as described (Hara et ai., 1996a) . Arterial blood pH and oxygen (P a02) and carbon dioxide (PaC02) partial pressures were mea sured before ischemia and 1 h after reperfusion (Corning 178; Ciba Corning Diag., Medford, MA, U.S.A.). Rectal and temporal is muscle temperatures were maintained at �37 and 36SC, respectively (FHC, Brunswick, ME, and BAT-12, Physitemp, Clifton, NJ, U.S.A.).
Ischemia model
The mouse left MCA was occluded for 3 h and reperfused as described previously with minor modifications (Hara et J Cereb Blood Flow Metab, Vol. 17, No.5, 1997 ai., 1996a). The dental resin-coated filament was introduced into the internal carotid artery through the common ca rotid artery up to the origin of the anterior cerebral artery (ACA) so as to occlude the MCA and posterior communi cating artery. Three hours after ischemia, animals were briefly reanesthetized with halothane and the filament with drawn.
[3H]L-NNA binding was studied in SV-129 mice at 15 min, 1 h, and 3 h of MCA occlusion and also after reperfusion for 10 min, 3 h, 24 h, 3 days, and 7 days (n = 4-6 in each group). In addition, [3H]L-NNA binding was examined 3 h after reperfusion in C57blackl6, type I, or type III NOS mutant mice.
NMD A -induced neurotoxicity
Mice were anesthetized with halothane (2.5% for in duction, 1-1.5% for maintenance) and the head was fixed in a stereotaxic frame (David Kopf, Tujunga, CA, U.S.A.). Three-tenths microliter containing 67 mM NMDA (20 nmol, dissolved in 0.1 M phosphate-buffered saline) was injected by a Hamilton syringe (26 G) at 0.5 mm ante rior and 2 mm lateral to bregma and -2.5 mm below the dura over 2 min. The needle was kept in place for an additional 8 min. Mice were killed after 3-48 h and brains were rapidly removed. The area of the lesion (striatum 3.5 mm posterior from olfactory bulb) was measured by an image analysis system (M4; Imaging Research, St. Cath arines, Ontario, Canada) and integrated to calculate volume.
Tissue preparation and histopathology
Mice and rats were killed by decapitation under deep halothane anesthesia and brains were rapidly removed. The tissues were immediately frozen in powdered dry ice and stored at -70°C. Coronal sections, 12 (ischemia study) or 20 (neurotoxicity study) ,urn, were cut in a cryostat at -18°C (Leitz 1720; Leica, Deerfield, IL, U.S.A.) and thaw mounted onto gelatin-coated slides [1 % gelatin and 0.1 % CrK(S04)2].
Adjacent sections were stained with hematoxylin/eosin for evaluation of neuronal damage after ischemia or excito toxicity.
[3H]L-NNA auto radiographic binding assay
The method for the autoradiographic visualization of [3H]L-NNA binding has been described previously (Hara et ai., 1996b) . Sections were brought to room temperature and preincubated for 15 min in 50 mM Tris-HCI (pH 7.3), then incubated for 30 min in 50 mM Tris-HCl buffer con taining 10 mM CaCI2, 10 ,uM o-NNA (RBI, Natick, MA, U.S.A.), and 25 nM �-nitro-L-[2,3,4,5-3H]arginine hydro chloride WH]L-NNA, specific activity 48-57 Ci/mmol; Am ersham, Arlington Heights, IL, U.S.A.). The sections were then washed twice for 5 min in ice-cold buffer and rinsed for 10 s in ice-cold distilled water to eliminate residual buffer. After drying with cold air, the slides were tightly apposed to 3H-Hyperfilm (Amersham) together with triti ated polymer standards CH microscale; Amersham) and exposed at 4°C for 6 weeks.
Nonspecific binding was defined as that remaining in the presence of an excess of unlabeled L-NNA (10 ,uM; Sigma). Ten micromolar o-NNA was included in the incubation buffer for all conditions to minimize nonspecific [3H]L NNA binding (Hara et ai., 1996b) . Specific binding was determined by subtracting the nonspecific binding from the total binding in serial sections.
To evaluate the specificity of [3H]L-NNA binding, we determined the displacing effects of 7-nitroindazole (7-NI) (100 p,M; Tocris Cookson, St. Louis, MO, U.S.A.) and aminoguanidine (100 p,M; Sigma).
To evaluate the�selectivity of [3H]L-NNA binding, frozen sections from pig aorta (12 p,m) were incubated with ligand or with rat spleen tissue sections taken 6 h after LPS injec tion (5 mg/kg i.p.) as described.
Saturation studies were performed by incubating adja cent sections with increasing concentrations of [3H]L-NNA (5-160 nM ) in the presence of 10 p,M unlabeled o-NNA (total binding) and in the presence of 10 p,M unlabeled 0-NNA and L-NNA (nonspecific binding). The dissociation constant (Kd) and the density of binding sites (Emax) were determined by Scatchard analysis (1949) .
Since the quenching of tritium is greater in white than in the gray matter (Kuhar and Unnerstall, 1985) , an apparent decrease in binding density could result if there were a change in the proportion of gray and white matter in the type I mutant mouse. Histopathological studies, however, revealed no such change. Furthermore, the binding pattern, using the tritiated ligands [3H]PN200-110 (L-type Ca2+ channels) or [3H]phorbol-12,13-dibutyrate (protein kinase C), was similar in wild-type and mutant mouse brain (H. Hara and M. A. Moskowitz, unpublished data).
Densitometric analysis
Films were developed in Kodak D-19 and fixed in Kodak Rapid Fixer, according to the manufacturer's instructions. The optical density of the regions of interest [striatum (caudate putamen), amygdala (amygdalohippocampal area, amygdalopiriform transition, basolateral and ba some dial amygdaloid nuclei, posterolateral and posterome dial cortical amygdaloid nuclei), MCA territory (temporal cortex area 3 and perirhinal cortex), and ACA territory (retrosplenial agranular cortex and retrosplenial granular oortex)) was measured by a computer-assisted image analy sis system. In the striatum, the sampled area was adjusted to the shape of the lesion. In the other areas (i.e., cortex, hippocampus, amygdala), the shape and site of the regions of interest were kept constant in control animals and ani mals with lesions. The relationship between optical density and radioactivity was examined with reference to the tri tium standards co-exposed with the tissue sections. The optical density of the brain regions measured in the present study was in a range in which the optical density and the radioactivity of the 3H microscale showed a near linear relationship. The densities of NOS binding are expressed in femtomoles bound [3H]L-NNA per milligram tissue using the [3H]L-NNA concentration of 5-160 nM.
NOS catalytic activity
Total NOS catalytic activity was measured by the conver sion of [3H]arginine to [3H]citrulline according to the method of Bredt and Snyder (1990) with minor modifica tions as previously described (Hara et ai., 1996a) . Selective measurement of calcium-independent NOS (type II NOS) activity was performed by omitting calcium and calmodulin in the reaction mixture and adding the co-factor (6R)-5,6,7,8-tetrahydro-L-biopterin (50 p,M; RBI, Natick, MA, U.S.A.).
Quantitative reverse transcription polymerase chain reaction
To determine whether increased [3H]L-NNA binding during ischemia is associated with increased NOS transcrip- Temporal muscle temperature COC)
Before ischemia 36.8 ::': 1. 1 36.7 ::': 0.6 36.5 ::': 0.5 37.0 ::': 0.7 1 hr after reperfusion 36.9 ::': 0.5 36.7 ::': 0.8 36.6 ::': 0.5 37.1 ::': 0.6 n = 5 pcr group (mean::,: SD). Arterial blood samples were obtained from the femoral artery. Thirty-,uL samples were withdrawn twice before ischemia and 1 hour after reperfusion. There are no significant differences between groups.
tion, RNA was isolated from ischemic and contralateral control mouse brain at different time points following MCA occlusion by the guanidinium isothiocyanate method (Chirgwin et aI., 1979) . RNA quality and average molecular size were determined by formaldehyde agarose gel electro phoresis.
First strand cDNA was synthesized using a fixed amount (5 ,ug) of iJrain mRNA in a 20-/Ll reaction using Superscript II reverse transcriptase (mRNA Pre amplification Re agents; Gibco BRL). One-tenth of the cDNA was used as
.1 ** template for polymerase chain reactions (PCRs) to amplify sequences corresponding to type I NOS, type III NOS, type II NOS, and actin. Type I NOS primers are as follows: Bl primer: 5'CCT TAGAGAGTAAGGAAGGGGGCGGG3' (26-mer); B2 primer: 5'GGGCCGATCA TTGACGGCGAGAATGA TG3' (2S-mer). These primers amplify a 404-bp fragment from type I NOS cDNA. Type III NOS primers are as follows: El primer: 5'GGGCTCCCTCCTTCCGGCTGC CACC3' (25-mer); E2 primer: 5'GGATCCCTGGAA AAGGCGGTGAGG3' (24-mer). These primers amplify a 254-bp fragment from type III NOS cDNA. Type II NOS primers are as follows: 11 primer: 5' ATCAGGAACC TGAAGCCCCAGGAC3' (24-mer); 12 primer: 5'TGTT GCCAGATTT CTCTGCACGGT3' (24-mer). These prim ers amplify a 33S-bp fragment from type II NOS cDNA. Each NOS primer is specific to its isoform and does not prime the other NOS isoforms. The actin primers are as follows: Al primer: 5'ATGGATGACGATATCGCTG3' (19-mer); A2 primer: 5'ATGAGGTAGTCTGTCAG GT3' (19-mer). These primers amplify a 600-bp fragment from actin mRNA.
The PCR reactions contained 1.5 mM MgCh and 0_2 nmol of each primer. Denaturating was at 94°C for 30 s, annealing at 55°C (actin and type II NOS) or 60°C (type I and III NOS) for 30 s, and polymerizing at noc for 60 s. Pilot reactions indicated that 35 cycles was neces sary to detect the products. Twenty microliters of each reaction was loaded onto 1% agarose gels in the presence of 0.1 ,ug/ml ethidium bromide and electrophoresed at SO V. The HaeIII digest of ¢X was used as molecular weight markers and as internal calibration controls for densitome try. The gels were photographed and scanned into a Macin tosh 7100/S0 using Silverscanner and NIH Image 1.60 soft ware, with settings 400 dpi and 256 gray scale.
Image analysis was performed by inverting the image' and calibrating for optical density to record relative DNA quantity. The intensity of the molecular weight marker bands was used to confirm that optical density is linearly proportional to the amount of DNA on each gel. The lanes were then analyzed and plotted, and the areas under each band were determined. All results were expressed as rela- tive amounts to the control lO-min sample (defined as 100%).
The validity of the technique was confirmed by using fixed amounts of brain RNA (5 p,g) as starting material for reverse transcription (RT). The proportion of type I NOS mutant mRNA to wild-type mRNA was varied, from 100% type I �OS mutant (no wild-type mRNA) to 0% type I NOS mutant (100% wild-type RNA). The total amount of RNA was constant, but the level of type I NOS mRNA varied between 0 and 100%. The amount of PCR product varied according to the amount of type I NOS RNA present.
Statistical analysis
Data are presented as means:±: SD. Statistical compari sons were made by one-or two-way analysis of variance (ANOY A) and Dunnett's multiple-range, Turkey's multiple-range, or Student's t test using the software super ANOYA (Abacus Concepts, Berkeley, CA, U.S.A).
RESULTS
Physiology
The MABPs of wild-type and mutant mice were as reported previously (Huang et ai., 1995) . Type III NOS mutant mice were hypertensive (Table 1) . Immediately after MCA occlusion and during isch emia, rCBF decreased to 10-20% of baseline (Fig.  1) . After reperfusion, rCBF immediately returned to preis chemic levels in SV-129 and type I NOS mutant mice, whereas recoveries were gradual and incom plete in C57black/6 and type III NOS mutant mice (p < 0.05, C57black/6 vs. SV-129; p < 0.01, C57blackl 6 vs, type I NOS mutant mice; 5 min after reperfu sion) (Fig. 1 ). There were no significant group differ ences in heart rate (data not shown), arterial blood gases and pH, or rectal and temporalis muscle tem- Vol. 17, No.5, 1997 perature before ischemia or after reperfusion (Ta ble 2).
Transient ischemia
[3H]L-NNA binding in normal brains was consis tent with our previous report (Hara et ai., 1996b) . At baseline, type I NOS mutant mice displayed very low binding, whereas the binding in type III NOS mutant was similar to wild-type. Binding did not change 15 min after MCA occlusion, but began to increase 1 h later (although not statistically signifi cantly). Binding significantly increased in all the isch emic regions (striatum, cortical MCA territory, and amygdala) 3 h after MCA occlusion (no reperfusion) and was still increased 10 min and 3 h after reperfu sion. Binding returned to control levels 1 day after reperfusion (Fig. 2) . A small decrease below base line was observed in amygdala and cortex after 7 days (Fig. 2) . Radioligand binding in the ACA terri tory and in contralateral brain did not change during ischemia or reperfusion. A large increase in binding to the ischemic zone (striatum, amygdala, and cortical MCA territory) was found in C57black/6 and type III mutants 3 h after reperfusion. For example, [3H]L NNA binding values in striatum in SV-129, C57blackl 6, and type III mutant mice were 9.1 ± 1.7 vs 22.9 :±: 10.1 fmollmg tissue (contralateral vs. ipsi lateral, mean ± SD, n = 6, P < 0.01), 9.6 ± 1.8 vs. 34.3 ± 8.5 fmol/mg (n = 5, P < 0.01), and 6.0 ± 2.2 vs. 17.2 ± 7.0 fmollmg (n = 6, P < 0.01), respectively. However, no increase was observed in type I NOS mutant mice (1.9 ± 1.8 vs. 2.3 ± 2.0 fmoll mg tissue, n = 6) ( Fig. 3) . A similar pattern was found ' .. 
Saturation studies
[3H]L-NNA binding was saturable and of high af finity. A three-to fivefold increase in maximum bind ing (Bmax) was found in the ischemic regions 3 h after reperfusion. No change in the dissociation constant (Kd) was observed ( Fig. 4; Table 3 ).
Ligand selectivity
A high density of [3H]L-NNA binding was ob served in the endothelium of pig aorta (Fig. 5) . After LPS injection, type II NOS catalytic activity increased in rat spleen from <0.3 to 21.1 :!: 0.5 fmol/mg wet wt/min (n = 3). However, there was no corresponding change in the distribution or density of [3H]L-NNA binding at this time (Fig. 6B ). There were no differ ences in Ca2+ -dependent NOS (type I and III) be tween LPS-and saline-treated animals.
Intrastriatal NMDA injections
NMDA increased binding by 30% starting 6 h fol lowing injection and reached a peak (200-230%) at 24-48 h (Fig. 7B-D) . Binding in the ipsilateral hippo campus did not change (data not shown). Forty-eight hours after NMDA injection, wild-type littermate controls showed the largest increase, followed by type I NOS heterozygotes. There was only a small eleva tion in [3H]L-NNA binding in type I NOS mutant mice. [3H]L-NNA binding values in lesion area 48 h after intrastriatal NMDA injection in type I NOS+1+ (sham, no NMDA injection), type I NOS+1+, type I NOS+1-, and type I NOS-1-were 8.9 :!: 2.0 vs. 9.1 :!: 2.0 (mean:!: SD, contralateral vs. ipsilateral, n = 5), 8.4 :!: 1.6 vs 19.3 :!: 4.9 (n = 5, P < 0.01, ANOV A followed by Student's t test), 6.6 :!: 2.2 vs. 13.1 :!: 5.4 (n = 6, p < 0.01), and 4.0 :!: 0.9 vs. 6.0 :!: 1.1 (n = 5, P < 0.01) fmol/mg, respectively. Consistent with previous findings, NMDA lesion size was smallest in type I mutant mice ( Fig. 7 A and E). [3H]L-NNA binding at 0, 3, 6, 12, 24, and 48 h after NMDA injection in striatum was 100 :!: 0 (% of contralateral side, mean:!: SD, n = 5), 105 :!: 3 (n = 5), 130 :!: 3 (n = 5), 163 :!: 4 (n = 6, P < 0.01 compared with be fore injection; time 0 h, ANOV A followed by Dun- nett's test), 329 ::!: 22 (n = 4, P < 0.01, and 295 ::!: 11 (n = 4, P < 0.01) fmol/mg, respectively.
Changes in NOS catalytic activity
Twenty-four hours after NMDA llljection, total NOS catalytic activity was 7.6 ::!: 1.1 (mean ::!: SD, n = 4) and 4.5 ::!: 1.7 (n = 4) fmol/mg wet wtlmin in contralateral and ipsilateral striatum, respectively (p < 0.05, Student's t test). Type II NOS catalytic activity was below the level of assay detection at this time.
RT-PCR following transient ischemia
RT-PCR was used to quantitate changes in mRNA levels for each NOS isoform. First, we confirmed the validity of the technique. Using a fixed total amount of RNA, we varied the level of type I NOS mRNA between 0 and 100% of wild-type levels by combining wild-type brain RNA with type I NOS mutant brain J Cereb Blood Flow Metab, Vol. 17, No.5, 1997 RNA. With use of these mixtures, first strand cDNA was synthesized and used as template for PCR with type I NOS-specific primers. Under the reaction con ditions, the amount of PCR product varied according to the amount of type I NOS RNA present in the initial RNA sample (r = 0.97, P < 0.001, y-test).
We determined the amount of each NOS isoform during reperfusion for 10 min, 30 min, 60 min, and 3 h. RNA was isolated from ischemic and contralat eral control hemispheres. Type I NOS mRNA levels began to increase at 10 min and persisted for 3 h (Figs. 8A and 9 ). The amount of PCR product was > 150% of control values. During this time, the level of type I NOS in the control samples diminished to -70% of its original value.
Type III NOS mRNA showed a similar decline, and there was no difference in type III NOS mRNA levels between ischemic and control sides (Figs. 8B and 9) . Type II NOS mRNA could not be detected FIG.8 . Agarose gel of polymerase chain reaction (PCR) products reflecting mRNA'levels of type I nitric oxide synthase (NOS) (A), type III NOS (B), and actin (e) mRNA in the forebrain hemispheres after focal ischemia in mice. Focal ischemia was produced by middle cerebral artery occlusion with the use of an intraluminal filament. Forebrain hemispheres were rapidly removed at 10 min, 30 min, 1 h, and 3 h after occlusion and frozen by liquid nitrogen and kept in -70DC freezer until use. Total RNA was isolated from ischemic and contralateral (non ischemic) forebrain hemisphere, reverse transcribed, and amplified by PCR with the use of primers for each NOS isoform (see Materials and Methods). The PCR products were run on an agarose gel. Lanes 1, 3, 5, and 7 show the results 10 min, 30 min, 1 h, and 3 h, respectively, after ischemia in ischemic forebrain. Lanes 2, 4, 6, and 8 show the results in the nonischemic hemisphere. The leftmost lane shows standards. The amount of PCR product reflecting type I NOS mRNA was higher on the ischemic side. There were no differences in type III NOS and actin mRNA levels between ischemic and contralateral sides.
under these reaction conditions, although the primers were successfully used to detect type II NOS mRNA from the spleen of LPS-treated mice (data not shown). Actin mRNA was used as a control. The levels of actin mRNA showed a slight decline over 3 h, although there was no difference between the ischemic and control sides ( Figs. 8e and 9 ).
DISCUSSION
Focal cerebral ischemia and intrastriatal NMDA microinjection caused a robust increase in [3H]L NNA binding in mouse brain limited to the anatomi cal regions at risk. Enhanced binding was observed in SV -129, CS7b\ackI6, and type 111 NOS mutant mice and was displaced by 7-NI, a selective type I NOS inhibitor. Only a small increase was detected in the type I NOS-deficient mouse, and this may have been due to either type III NOS up-regulation or products of the type I NOS gene processed by alternative splic ing (Brenman et aI., 1996) . One such splice variant A. Type I NOS mRNA levels by AT-PCR lacks two exons, constitutes � 5% of type I NOS tran scripts (Ogura et aI., 1993) , but lacks the ability to synthesize NO from L-arginine (Ogura et aI., 1994) . Furthermore, alternatively spliced type I NOS has been identified in both mutant and wild-type mice and is � 80% as active as full-length type I NOS (Brenman et aI., 1996) . However, it is not known whether this isoform binds [3H]L-NNA. A decrease in [3H]L-NNA binding below baseline was observed in amygdala and cortex after 3 and 7 days (Fig. 2) . Ischemic infarction is well developed in mice 3 and 7 days following such a severe ischemic insult (3-h ischemia) (Yang et aI., 1994) . We cannot rule out the possibility that the development of isch emic infarction affected the kinetics of PH]L-NNA binding in this study, although the reduced binding at these later time points probably does represent less N OS protein within dead or dying tissue.
Despite II NOS, and actin mRNA after focal ischemia in mice by reverse transcription polymerase chain reaction (PCR). mRNA was mea sured at 10 min, 30 min, 1 h, and 3 h after middle cerebral artery occlusion. The gels in Fig. 8 were analyzed using NIH Image 1.60 after scanning. The intensity of the bands corresponding to the major PCR products was determined and plotted. IpSilateral, isch emic forebrain hemisphere; Contralateral, contralateral forebrain hemisphere; 00, optical density. and, as reported previously, decreases shortly after ischemia (Yoshida et aI., 1995) . NO levels, however, increase shortly after ischemia. Malinski et a1. (1993) detected enhanced NO production using a porphyrin coated microelectrode and electrochemical detection method. Increased brain nitrite, cyclic GMP levels (Kader et aI., 1993) , plus the formation of paramag netic adducts of NO after injection of diethyldithio carbamate (Mullins et aI., 1996) are consistent with enhanced NO production during ischemia. It is diffi cult to easily resolve this discrepancy, but it might reflect differences between those methods used to measure NO activity in vivo and in vitro or, for exam ple, the presence of NOS tissue inhibitors released during ischemia from sequestered compartments. Regardless, the observed differences in binding be tween groups (Figs. 3, 7-9; Table 3) were not likely to follow from differences in physiological parameters (e.g., MABP, rCBF) measured before ischemia and during the reperfusion period.
Several published studies suggest that type I NOS expression may be up-regulated after noxious insults in vivo and in vitro. In rats, type I NOS mRNA increases as early as 15 min after permanent focal ischemia (Zhang et aI., 1994) . In the same study, type I NOS immunoreactivity and NADPH-diaphorase positive neurons increased in the ischemic regions 1-24 h following ischemia in the rat. Other studies supported these findings (Endoh et aI., 1994; Peng et aI., 1996) . In addition, Kato et a1. (1994) found an increase in NADPH-diaphorase activity in CAl pyra midal neurons following global ischemia. Further more, O'Hearn et a1. (1995) reported that type I NOS was induced in cerebellar Purkinje cells following excitotoxic insults after ibogaine. Our data suggest that NOS binding sites increased during ischemia and that these increases persisted during reperfusion for several hours before returning toward baseline.
It appears unlikely that the increase in binding after NMDA injection was due to a physical interac tion between excitotoxin (Rao and Butterworth, 1996) and radiolabeled ligand or an artifact of ligand binding in ischemic brain. More likely, it was the result of an increase in type I NOS protein, as evi denced by the quantitative RT-PCR data (Figs. 8 and 9) and the increase in Bmax during reperfusion.
Moreover, the increase in [3H]L-NNA binding showed a gene dosage effect, being most robust dur ing NMDA excitotoxicity in wild-type > heterozy gote > type I NOS mutant brain (Fig. 7) .
Type II NOS catalytic activity was below detect able limits following intrastriatal NMDA injection as previously reported early after MCA occlusion in rats (Iadecola et aI., 1995; Yoshida et aI., 1995) . For unexplained reasons [3H]L-NNA does not bind type II NOS despite blocking enzyme activity both in vivo and in vitro.
[3H]L-NNA binding in spleen did not change after LPS, and aminoguanidine, a type II NOS inhibitor, weakly displaced the [3H]L-NNA binding after ischemia, indicating that under the conditions of the present study, amino guanidine was not specific for type II NOS and may not be appropriate to use a marker of type II NOS binding.
In conclusion, our results demonstrate the [3H]L NNA binding. increases during focal cerebral isch emia or NMDA excitotoxicity, reflecting a possible up-regUlation of type I NOS gene expression. Up regulation of NOS may play an important role in the pathogenesis of ischemic/excitotoxic disorders such as stroke and neurodegenerative diseases.
